CIK 0001807120 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Design Therapeutics, Inc.
Sign in to watch- Ticker
- DSGN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 823929248
- Phone
- 858-293-4900
- Business address
- 6005 HIDDEN VALLEY ROAD, SUITE 110, CARLSBAD, CA, 92011
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-06-09 | Gover Justin D. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-09 | Berger Heather A. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-09 | LAPPE RODNEY W Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-09 | Shapiro David Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-09 | Schmid John P. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-06-09 | George Simeon Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2026-03-31 | Shapiro David Director | Grant or award · Stock option (right to buy) | +60,000 | 60,000 | ||
| 2026-03-31 | Shapiro David Director | Grant or award · Stock option (right to buy) | +7,500 | 7,500 | ||
| 2026-01-02 | Burgess Julie Chief Accounting Officer | Grant or award · Stock option (right to buy) | +150,000 | 150,000 | ||
| 2026-01-02 | Jeffries Sean Chief Operating Officer | Grant or award · Stock option (right to buy) | +375,000 | 375,000 | ||
| 2026-01-02 | Gover Justin D. Director | Grant or award · Stock option (right to buy) | +45,000 | 45,000 | ||
| 2026-01-02 | Storgard Chris Chief Medical Officer | Grant or award · Stock option (right to buy) | +250,000 | 250,000 | ||
| 2026-01-02 | Shah Pratik President, CEO and Chairperson | Grant or award · Stock option (right to buy) | +750,000 | 750,000 | ||
| 2025-12-09 | Shah Pratik President, CEO and Chairperson | Grant or award · Stock option (right to buy) | +525,000 | 525,000 | ||
| 2025-12-09 | Shah Pratik President, CEO and Chairperson | Grant or award · Stock option (right to buy) | +525,000 | 525,000 | ||
| 2025-09-09 | Gover Justin D. Director | Grant or award · Stock option (right to buy) | +30,000 | 30,000 | ||
| 2025-09-09 | Gover Justin D. Director | Grant or award · Stock option (right to buy) | +15,833 | 15,833 | ||
| 2025-08-13 | William Arsani Director | Sale | −345,000 | $5.25 | $1.8M | 2,655,000 |
| 2025-08-13 | William Arsani Director | Sale | −217,627 | $5.25 | $1.1M | 1,000,000 |
| 2025-06-10 | William Arsani Director | Grant or award · Stock Option (right to buy) | +19,000 | 19,000 |
Page 1 of 7 · 135 trades